| Name | Title | Contact Details |
|---|
Newly combined with Baxalta, Shire is now the leading global biotechnology company focused on serving people affected by rare diseases and highly specialized conditions. These diseases are often misunderstood, under-diagnosed, and potentially life-threatening. Our 22,000 employees come to work every day with a common purpose: to develop and deliver breakthrough therapies that enable people with life-altering conditions to live their lives to the fullest. At Shire, we are dedicated to expanding, building and sustaining leadership across our key therapeutic areas through our extensive portfolio of products, innovative pipeline and collaborative approach to working with diverse partners around the globe. We strive to earn and keep the trust of our patients, their families and physicians, and all others who support and advance their care. Working together, the possibilities for our patients, healthcare partners and employees are unprecedented, with significant growth potential for our shareholders.
Avamere Family of Companies, a group of independent privately owned post-acute care companies, is dedicated to seniors` health and well-being. We take great pride in offering a continuum of care, which allows seniors to stay independent and active.
Decade of Discovery is a major research initiative led by the Minnesota Partnership for Biotechnology and Medical Genomics focused on preventing, optimally treating and ultimately curing diabetes.
Innovative Therapies is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PlayMaker Health`s post-acute software transforms provider claims into actionable business intelligence. Integrating within existing industry workflows, the platform, and mobile-first CRM unify market and sales performance data, delivering the actionable analytics and business intelligence post-acute providers need to accelerate growth and expand competitive market share.